论文部分内容阅读
上腔静脉综合征(SVCS)最常见于恶性肿瘤(如肺癌、淋巴瘤等)对血管壁的压迫和浸润,近年来随着中心静脉中长期留置导管或起搏器导线,血栓性 SVCS 发生率增多。有作者曾发现,经静脉造影证实,长期留置中心静脉导管(CVC)而未加抗凝治疗的患者中,导管周围血栓形成者约占37.5%～52%.作者回顾性分析 Clevelaad 门诊部收治的16例应用溶栓治疗的 SVCS 患者的资料,旨在评价溶栓治疗的安全性和疗效,同时找出影响溶栓成功的因素.
Superior vena cava syndrome (SVCS) is the most common malignant tumor (such as lung cancer, lymphoma, etc.) on the vessel wall compression and infiltration in recent years with the central venous catheter indwelling catheter or pacemaker wire, thrombotic SVCS incidence increase. Some authors have found that patients who underwent long-term indwelling CVC without anticoagulant therapy accounted for about 37.5% -52% of patients with peripheral thrombosis of the catheter, as evidenced by venography.We retrospectively reviewed the data from the Clevelaad Clinic Data from 16 SVCS patients treated with thrombolysis were evaluated for the safety and efficacy of thrombolytic therapy and to identify the factors that influence the success of thrombolysis.